69 related articles for article (PubMed ID: 2308780)
1. [Involvement of tumor necrosis factor in the generation of LAK killer cells].
Chouaib S; Blay JY
Pathol Biol (Paris); 1990 Jan; 38(1):47-52. PubMed ID: 2308780
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha: a costimulator for cytotoxic cell differentiation.
Chouaib S
Nouv Rev Fr Hematol (1978); 1991; 33(6):471-5. PubMed ID: 1818300
[TBL] [Abstract][Full Text] [Related]
3. Involvement of cyclic adenosine monophosphate in the interleukin 4 inhibitory effect on interleukin 2-induced lymphokine-activated killer generation.
Blay JY; Branellec D; Robinet E; Dugas B; Gay F; Chouaïb S
J Clin Invest; 1990 Jun; 85(6):1909-13. PubMed ID: 2161432
[TBL] [Abstract][Full Text] [Related]
4. Functional interactions of IL2 and TNF in the differentiation of LGL into LAK effectors.
Blay JY; Bertoglio J; Fradelizi D; Chouaib S
Int J Cancer; 1989 Oct; 44(4):598-604. PubMed ID: 2793231
[TBL] [Abstract][Full Text] [Related]
5. [Functional interaction between the tumor necrosis factor and interleukin 2 during induction of lymphokine activated killer cytotoxic activity].
Blay JY; Bertoglio J; Gay F; Fradelizi D; Chouaib S
C R Acad Sci III; 1988; 307(2):47-51. PubMed ID: 3138005
[TBL] [Abstract][Full Text] [Related]
6. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
Owen-Schaub LB; Gutterman JU; Grimm EA
Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408
[TBL] [Abstract][Full Text] [Related]
7. Characterization of OKT3-initiated lymphokine-activated effectors expanded with interleukin 2 and tumor necrosis factor alpha.
Yang SC; Owen-Schaub LB; Roth JA; Grimm EA
Cancer Res; 1990 Jun; 50(12):3526-32. PubMed ID: 2160321
[TBL] [Abstract][Full Text] [Related]
8. Functional interactions between interleukin-4, interleukin-2, and tumor necrosis factor-alpha for lymphokine-activated killer cell generation.
Blay JY; Branellec D; Robinet E; Gay F; Chouaib S
J Clin Lab Anal; 1990; 4(1):54-8. PubMed ID: 2313467
[TBL] [Abstract][Full Text] [Related]
9. Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2.
Chouaib S; Bertoglio J; Blay JY; Marchiol-Fournigault C; Fradelizi D
Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6875-9. PubMed ID: 3045826
[TBL] [Abstract][Full Text] [Related]
10. [The effect of interleukin-2, interleukin-4 and tumor necrosis factor on LAK cells activity].
Zeng Z; Si CW; Yu M
Zhonghua Yi Xue Za Zhi; 1994 Apr; 74(4):235-7, 256. PubMed ID: 7922766
[TBL] [Abstract][Full Text] [Related]
11. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
[TBL] [Abstract][Full Text] [Related]
12. TNF-alpha potentiation of the lymphokine-activated killer response of murine thymus cells.
Ujházy P; Maccubbin D; Eppolito C; Mihich E; Ehrke MJ
Lymphokine Cytokine Res; 1994 Apr; 13(2):99-106. PubMed ID: 8061121
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of various cytokines on the generation of rat LAK cells from their purified precursors.
Maghazachi AA
Immunology; 1990 Aug; 70(4):465-72. PubMed ID: 2118478
[TBL] [Abstract][Full Text] [Related]
14. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer.
Wang Z; Cheng Y; Zheng R; Qin D; Liu G
Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335
[TBL] [Abstract][Full Text] [Related]
15. On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity.
Spagnoli GC; Juretic A; Schultz-Thater E; Dellabona P; Filgueira L; Hörig H; Zuber M; Garotta G; Heberer M
Cell Immunol; 1993 Feb; 146(2):391-405. PubMed ID: 8174177
[TBL] [Abstract][Full Text] [Related]
16. Effects of IL-7 and IL-2 on highly enriched CD56+ natural killer cells. A comparative study.
Naume B; Espevik T
J Immunol; 1991 Oct; 147(7):2208-14. PubMed ID: 1717551
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.
Espevik T; Figari IS; Ranges GE; Palladino MA
J Immunol; 1988 Apr; 140(7):2312-6. PubMed ID: 3280680
[TBL] [Abstract][Full Text] [Related]
18. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
19. Synergy of human recombinant interleukin 1 with interleukin 2 in the generation of lymphokine-activated killer cells.
Crump WL; Owen-Schaub LB; Grimm EA
Cancer Res; 1989 Jan; 49(1):149-53. PubMed ID: 2783241
[TBL] [Abstract][Full Text] [Related]
20. Sequential TNF and TGF-beta regulation of expansion and induction of cytotoxicity in long-term cultures of lymphokine-activated killer cells.
Koberda J; Przepiorka D; Moser RP; Grimm EE
Lymphokine Cytokine Res; 1994 Apr; 13(2):139-45. PubMed ID: 8061115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
